Mechanistically, hepatic insulin resistance is known to dysregulate lipid metabolism, leading to lipolysis [34], which then leads to increased production of toxic lipids such as ceramides that have been reported to impair insulin signaling and mitochondrial function [35–38]. Here, INS is linked to Insulin resistance.